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Summary
The polymorphonuclear leukocyte (PMN)-derived ser-
ine proteases play a key role in immune complex (IC)-
mediated inflammation. However, the mechanisms by
which these proteases regulate inflammatory re-
sponse remain largely undefined. Here, we show that
IC-activated cathepsin G- and neutrophil elastase-
deficient (CG/NE) PMNs adhered normally to IC-
coated surfaces but did not undergo CD11b cluster-
ing and failed to initiate cytoskeletal reorganization
and cell spreading. As a result, CG/NE-deficient PMNs
exhibited severe defects in MIP-2 secretion and
reactive oxygen intermediates production. Exoge-
nously added CG, but not proteolytically inactive CG,
was sufficient to restore these defects. These find-
ings identify an important role for CG in integrin-
dependent PMN effector functions that are separate
from and downstream of integrin-dependent ad-
hesion.
Introduction
PMNs are an essential component of the host innate
response against invading pathogens. However, exces-
sive PMN responses are thought to contribute to the
development and perpetuation of autoimmune dis-
eases. Although many aspects of PMN activation lead-
ing to transmigration across the endothelial barrier
have been elucidated, the mechanisms that regulate
PMN activation and effector functions in the extracellu-
lar matrix (ECM) are still undefined.
One of the major mechanisms by which PMNs accu-
mulate and become activated at sites of inflammation
in noninfectious diseases is through the interaction with
IC. Binding of PMNs to IC through their Fc gamma re-
ceptors (FcγR) leads to phagocytosis, generation of re-
active oxygen intermediates (ROI), release of proteo-
lytic enzymes, and secretion of soluble inflammatory*Correspondence: cpham@wustl.edu
4 Present address: Genentech, Inc., South San Francisco, CA
94108.mediators (Ravetch, 1994). It has been known that IC
activation of PMNs requires the cooperation of FcγR
and β2 integrins, particularly Mac-1 (CD11b/CD18) on
PMNs (Jones et al., 1998; Zhou and Brown, 1994). In
addition, Mac-1-deficient PMNs have blunted re-
sponses to IC stimulation in vitro and decreased PMN
recruitment in a model of IC-mediated glomerulone-
phritis in vivo (Tang et al., 1997). Thus FcγR and inte-
grins play an important role in the development of IC-
mediated inflammation.
Cathepsin G (CG), neutrophil elastase (NE), and pro-
teinase 3 (PR3) are a family of highly related neutral
serine proteases expressed in the primary granules of
PMNs (Owen and Campbell, 1999). The importance of
NE and CG during infections has been clearly demon-
strated in serine protease-deficient mice. These mice
are more susceptible to various pathogens, including
gram-positive and -negative bacteria and certain fungal
organisms (Belaaouaj et al., 1998; Reeves et al., 2002;
Tkalcevic et al., 2000). Recent studies have also shown
that mice lacking in CG and NE are resistant to IC-
mediated diseases, further suggesting an active role for
these proteases in immune responses other than their
antibacterial functions. Consistent with this emerging
view of protease functions, studies have demonstrated
that NE-deficient mice are resistant to an experimental
mouse model of bullous pemphigoid (Liu et al., 2000),
and CG/NE mice were resistant to an IC-mediated, neu-
trophil-dependent arthritis model (Adkison et al., 2002).
In the later study, there was no PMN accumulation in
the joints of CG/NE mice that received arthrogenic anti-
bodies. Currently, the role of serine proteases in PMN
transmigration and recruitment remains controversial.
Although some studies suggest that serine proteases
might be required for the migration of PMNs to inflam-
matory sites (Carden and Korthuis, 1996; Carney et al.,
1998; Woodman et al., 1993), others reported that CG
and NE are not essential for normal chemotaxis to vari-
ous inflammatory stimuli (Hirche et al., 2004; Huber and
Weiss, 1989; Mackarel et al., 1999). Thus, the fact that
PMNs deficient in CG and NE exhibit normal chemo-
taxis but do not accumulate in vivo in response to IC-
induced inflammation points to an undefined role for
these proteases in regulating leukocyte recruitment.
According to the current paradigm, CG and NE,
secreted upon PMN activation, are thought to degrade
specific target molecules of the ECM, thus contributing
to tissue damage and the propagation of inflammation.
Recent reports suggest, however, that serine proteases
remain bound to the cell surface membrane upon re-
lease from primary granules, where they become resis-
tant to circulating endogenous protease inhibitors pres-
ent in the serum (Owen et al., 1995a, 1995b). Hence,
the mode of action of membrane bound serine prote-
ases may be more complex than previously thought.
These studies and the results from the experimental ar-
thritis model aforementioned led us to consider the un-
explored notion that the membrane bound form of ser-
ine proteases may directly regulate PMN activation and
effector functions. In this report, we test this hypothesis
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by examining the response of purified PMNs to IC stim- l
ulation in an in vitro cell culture system in which PMN C
activation can be evaluated independent of other cell p
types. Our findings suggest that neutrophil-derived ser- v
ine proteases regulate PMN effector functions by mod- l
ulating integrin clustering. T
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sDefective Chemokine Release in the Subcutaneous
Air Pouch of CG/NE Mice e
oThe migration of PMNs to inflammatory sites is regu-
lated by the activity of CXC chemokines such as MIP-2 P
tand KC (Olson and Ley, 2002). We reasoned that the
absence of PMNs in CG/NE joints in the arthritis model d
swas due to a defect in the local generation of a chemo-
tactic gradient. To test this idea, we turned to the sub- C
dcutaneous air pouch model that offered us a direct way
to assess the number of leukocytes recruited and the g
achemokine response to specific stimuli. When inflam-
mation was induced by in situ IC formation and air a
bpouches were enumerated for leukocyte counts, CG/
NE mice exhibited a significant reduction in cell number M
C(>50%, p < 0.05) (Figure 1A) as well as chemokine pro-
duction (>3-fold reduction in MIP-2 and KC, p < 0.01) d
(Figures 1B and 1C). Air-pouch inflammation induced
by the yeast particle zymosan also led to a significant p
Preduction in MIP-2 and KC release (p < 0.01 and 0.001,
respectively) in the CG/NE air pouch (Figures 1E and s1
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Figure 1. Defective Chemokine Production in CG/NE Mice i
cAir pouches were formed as described in Experimental Procedures.
For IC formation (A–C), mice were injected with 20 mg/kg chicken t
egg albumin (OVA) intravenously followed by injection of 800 g e
of rabbit anti-OVA Abs in the air pouch (n = 4–6 mice per group). r
Alternatively, mice were injected with 300 g of zymosan in 1 ml of
saline in the air pouch (D–F; n = 4 mice per group). Leukocyte
counts in air pouch were enumerated after 4 hr; MIP-2 and KC in C
the lavage fluid were measured by ELISA. Asterisks denote signifi- D
cant difference between wt and CG/NE mice. *p < 0.05, **p < 0.01, S
***p < 0.001. All values represent mean ± SD. s
dF). In this case, the number of leukocytes recruited at
our hr after injection of zymosan was equivalent in
oth wild-type (wt) and mutant mice (Figure 1D). Zymo-
an has been shown to be a strong activator of the
omplement system, resulting in the formation of C5a,
potent PMN chemoattractant (Fearon and Austen,
977). Thus, the C5a gradient generated by zymosan is
ikely responsible for the equivalent numbers of PMNs
nitially recruited into the air pouch, as CG/NE PMNs
hemotax normally in response to C5a (see Figure S1
n the Supplemental Data available with this article on-
ine). As C5a has a short half-life, other chemoattrac-
ants are likely required to sustain the recruitment of
eukocytes over time. In support of this notion, we pre-
iously detected a significant reduction in the number
f PMNs recruited to the air pouch of CG/NE mice at 12
r post zymosan injection (Adkison et al., 2002). PMNs
hemselves have been shown to synthesize and release
XC chemokines when activated (Scapini et al., 2000).
MNs are among the earliest cell types recruited to an
nflammatory site, and their ability to secrete chemo-
ines may constitute a mechanism by which PMNs can
nfluence the early trafficking of inflammatory cells. Be-
ause CG and NE are PMN-specific proteases, we pos-
ulate that these enzymes may directly regulate PMN
ffector functions that in turn shape the inflammatory
esponses.
G and NE Are Required for Optimal Adhesion-
ependent Effector Functions
ustained PMN effector functions in response to IC
timulation require adhesion and have been shown to
epend on the ligation of both FcγR and β2 integrins
Jones et al., 1998; Zhou and Brown, 1994). To recapitu-
ate these requirements in an in vitro system, wt and
G/NE PMNs were stimulated on immobilized IC in the
resence of Ca2+ and Mg2+ and TNF-α priming. IC-acti-
ated wt PMNs in adherent culture released significant
evels of the chemokine MIP-2, but not KC, IL-1β, or
NF-α (data not shown). In contrast, MIP-2 release by
G/NE and CG-deficient PMNs was markedly reduced
ompared to wt PMNs (Figure 2A). PMNs lacking NE
lone were minimally compromised in MIP-2 release,
uggesting that CG has a critical role in regulating this
ffector function (Figure 2A). We also examined NADPH
xidase activation in response to IC stimulation. Wt
MNs generated a robust respiratory burst, whereas
he amount of ROI produced by CG/NE PMNs was re-
uced by >50%. PMNs lacking CG exhibited a more
evere defect than those lacking NE, suggesting that
G has a predominant role in IC-mediated ROI pro-
uction (Figure 2B). Taken together, these results sug-
est an unexpected role for PMN-derived serine prote-
ses—that of modulating PMN effector functions during
dhesion-dependent IC stimulation—as demonstrated
y the release of chemokines and ROI production.
oreover, this regulatory effect is mediated mainly by
G, indicating that CG and NE are not absolutely re-
undant in function.
To test if the reduction in MIP-2 secretion and ROI
roduction was the result of intrinsic defects in CG/NE
MNs, we examined PMN effector functions in re-
ponse to phorbol 12-myristate 13-acetate (PMA), a
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681Figure 2. Defective Adhesion-Dependent Functions in CG/NE PMNs
MIP-2 release (A) and ROI production (B) by TNF-α-primed, IC-stimulated PMNs were measured over time. MIP-2 release at 2 hr (C) and ROI
production (D) by wt and protease-deficient PMNs stimulated with PMA. Data represent the mean ± SD of duplicate samples for MIP-2 and
triplicate samples for ROI and are representative of at least four independent experiments. Data are presented as percentage of ROI produced
by wt PMNs at 150 min.
(E) PMNs were stimulated on anti-OVA Abs or IC in the presence of brefeldin A and stained for intracellular MIP-2.
(F) The percentage of MIP-2 released was calculated by dividing MIP-2 in the supernatant by the total amount of MIP-2. Data are representa-
tive of four independent experiments.pharmacologic agent known to bypass adhesion-depen-
dent activation of PMNs. Both MIP-2 and ROI pro-
duction were comparable in wt and protease-deficient
PMNs (Figures 2C and 2D), suggesting that these en-
zymes are not required when surface receptor ligation
is bypassed. In contrast, MIP-2 release was not de-
tected when cells were stimulated in suspension with
other PMN agonists such as TNF-α or formyl-methio-
nyl-leucyl-phenylalanine (Figure S2).
CG and NE Are Required to Regulate MIP-2 Release
We next determined if reduced MIP-2 levels by IC-stim-
ulated CG/NE PMNs were a result of decreased synthe-sis or decreased release of the chemokine. Wt and CG/
NE PMNs produced similar levels of MIP-2 by intracel-
lular staining (Figure 2E). Moreover, detection of MIP-2
transcripts by reverse-transcriptase-polymerase chain
reaction (RT-PCR) from IC-stimulated PMNs revealed
no significant difference between wt and CG/NE cells
(data not shown). In contrast, wt PMNs released ap-
proximately 46% of the total MIP-2 during IC stimula-
tion, whereas CG/NE PMNs released less than 15% of
the total MIP-2 (n = 4, p < 0.001) (Figure 2F). Studies
have shown that membrane shedding of CXC chemo-
kine by proteases regulates their bioavailability (Li et
al., 2002). To rule out the possibility that MIP-2 re-
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Cmeabilized PMNs for MIP-2 with specific monoclonal
BAbs but did not detect membrane expression of the
pchemokine on activated PMNs by flow cytometry (data
Pnot shown). Together, these results suggest that the de-
pcrease in MIP-2 levels by CG/NE PMNs is due to a fail-
Cure in release and not a failure in synthesis or mem-
obrane shedding of MIP-2.
hWe next determined if release of prestored granule
Icontent was also affected in CG/NE PMNs. Secretory
vgranule release, as measured by the upregulation of
tCD11b in the presence of TNF-α, was normal in prote-
yase-deficient PMNs compared with wt PMNs (Figure
tS3A). Likewise, release of MMP-9 from gelatinase (terti-
mary) granules and β-glucuronidase from primary gran-
aules was equivalent in all genotypes (Figures S3B and
CS3C). These results suggest that release of prestored
igranule content proceeds normally in the absence of
fserine proteases.
CXC chemokines have been shown to trigger in-
tcrease in integrin affinity leading to enhanced integrin-
omediated adhesive functions (Laudanna et al., 2002).
fBecause the receptor for MIP-2 (the G protein-coupled
ireceptor CXCR2) is present on PMNs, MIP-2 could po-
itentially enhance MIP-2 release and ROI production by
P
binding to CXCR2. To examine whether released MIP-2
c
activates integrin-dependent functions in this in vitro
f
system, we pretreated wt and CG/NE PMNs with dif-
l
ferent doses of pertussis toxin (PTX), an inhibitor of G a
protein-coupled receptors (Baggiolini et al., 1997). PTX m
did not affect MIP-2 release by wt or CG/NE PMNs (Fig- h
ure S4A) but blocked chemotaxis induced by IL-8 (the n
homologue of MIP-2, Figure S4B). In addition, PMNs a
deficient in CXCR2 released equivalent levels of MIP-2 a
and ROI compared to wt PMNs stimulated with IC (Fig- c
ures S4C and S4D). These results suggest that released (
MIP-2 does not enhance adhesion-dependent PMN ef- a
fector functions in this in vitro system. N
a
l
CG and NE Are Required for Optimal PMN p
Activation on Integrin Ligands t
We next examined the requirement for serine proteases i
when PMNs were directly plated on surfaces coated a
with ligands for both β1 and β2 integrins. ROI prod- i
uction on both fibrinogen (a ligand for β2 integrin) and s
fibronectin (a ligand for β1 integrin) was reduced in CG/ C
NE PMNs (Figures 3A and 3B). Next we examined c
MIP-2 release by PMNs plated on these ligands. Wt and t
CG/NE PMNs plated on fibrinogen and fibronectin did
not release any detectable amount of MIP-2, even in C
the presence of TNF-α priming (data not shown). In S
contrast, release of MMP-9 and β-glucuronidase was I
normal after plating on fibrinogen (Figure S5). Cross- g
linking with anti-CD11b and anti-CD29 Abs (an anti-β1 n
integrin Ab), but not anti-CD16 Abs or isotype control, I
was sufficient to induce release of MIP-2 in wt PMNs P
(Figure 3D). In contrast, CD11b and CD29 crosslinking t
in CG/NE PMNs failed to elicit a similar response (Fig- c
ure 3D). These and the above results suggest that CG e
and NE have a critical role in regulating integrin-medi- g
cated responses in PMNs.MN-Derived Serine Proteases Regulate
ytoskeleton Reorganization and Integrin Clustering
ecause adhesion has been linked to chemokine ex-
ression and shown to influence ROI production in
MNs (Kessel et al., 1998; Rezzonico et al., 2001; Shap-
ell et al., 1990), we next determined whether activated
G/NE PMNs adhered normally on immobilized IC. We
bserved no significant difference in the number of ad-
erent CG/NE PMNs on IC-coated surfaces (Figure 4A).
n addition to adhesion, a hallmark response of acti-
ated PMNs is the initiation of cytoskeletal reorganiza-
ion and cell spreading after adhesion (Yamada and Mi-
amoto, 1995). To investigate if CG and NE are required
o regulate this response, we assessed F-actin poly-
erization and cell spreading with phalloidin staining
nd fluorescence microscopy. In contrast to wt PMNs,
G/NE PMNs exhibited significantly reduced cell spread-
ng and failed to form a distinct lamellipodia that was
ound in activated wt PMNs (Figure 4B, top).
Because cytoskeletal reorganization is critically linked
o signals from integrins (DeMali et al., 2003), the lack
f cell spreading seen in CG/NE PMNs suggests a de-
ect in integrin-dependent functions. Previous studies of
ntegrin signaling identified an inside-out signaling step
nitiated from specific receptors (i.e., FcγR ligation in
MNs) that is first required to induce conformational
hanges in integrins, leading to increased receptor af-
inity for ligand binding. This initial activation step re-
eases integrins from the actin cytoskeleton restraint,
llowing lateral mobility of integrins within the plasma
embrane, leading to increased integrin avidity and en-
ancing subsequent cellular responses (outside-in sig-
aling). In many cell systems, this increase in avidity is
ppreciated in the form of receptor clustering, in which
ctivated integrins appear as distinct aggregates that
an be detected by immunofluorescence microscopy
Hogg et al., 2002). Because CD11b is essential for the
ctivation of PMNs on IC, we examined the role of CG/
E in regulating the clustering pattern of CD11b. IC-
ctivated, adherent wt PMNs displayed a distinct circu-
ar pattern of CD11b staining, probably representing
oints of contact with IC-coated surfaces (Figure 4B,
op). These CD11b aggregates were essentially absent
n CG/NE PMNs (Figure 4B, middle). This difference in
ppearance was not the result of a lower density of β2
ntegrins on CG/NE PMNs, as flow cytometry revealed
imilar surface expression of CD11b between wt and
G/NE PMNs (Figure 4C). Hence, CG and NE have a
ritical role in the regulation of integrin clustering in ac-
ivated PMNs.
G and NE Are Required to Regulate Intracellular
ignaling in PMNs
f CG and NE were required to properly regulate β2 inte-
rin functions, one would predict that intracellular sig-
aling events in CG/NE PMNs would also be affected.
n accordance with this notion, IC-activated CG/NE
MNs exhibited increased total tyrosine phosphoryla-
ion (Figure 4D). The Syk tyrosine kinase is an essential
omponent of integrin signaling in neutrophils (Mocsai
t al., 2002), and signaling proteins downstream of inte-
rin-mediated Syk activation include the adaptor mole-
ule Vav1. We found that phosphorylation of both Syk
Cathepsin G Regulates Neutrophil Functions
683Figure 3. Defective Adhesion-Dependent CG/NE PMN Functions Stimulated with Direct Integrin Ligands
ROI production from purified PMNs plated on fibrinogen (A) or fibronectin (B) in the absence or presence of TNF-α. Note that dihydrorhodam-
ine 123 measures total ROI production (intracellular and released).
(C) PMNs were plated on anti-CD16, anti-CD11b, and anti-CD29 Abs (40 g/ml) or isotype control. Supernatant was collected after 2 hr and
assayed for MIP-2. Data are representative of at least three independent experiments.
All values represent mean ± SD.and Vav1 was deregulated in the absence of CG and
NE (Figures 4D and 4E). In addition, IC-induced activa-
tion of β2 integrins requires phosphoinositide 3-kinase
(PI3-K) and is known to induce phosphorylation of pax-
illin (Chen et al., 2003). Phosphorylation of these mole-
cules was likewise increased in CG/NE PMNs (Figure
4D). In contrast, activation of the GTPase Rac1 was sig-
nificantly decreased in CG/NE PMNs (Figure 4F). Inte-
grin clustering leads to activation of the Rho family of
GTPases, which are known to be key regulators of the
actin cytoskeleton (Burridge and Wennerberg, 2004).
Defective Rac1 activation is therefore consistent with
the absence of lamellipodia formation and cell spread-
ing observed in CG/NE PMNs. Thus, normal intracellu-
lar signaling downstream of integrins requires the pres-
ence of CG and NE.
Cytoskeletal Reorganization Is Required for Optimal
PMN Effector Functions
Our results suggest that in the in vitro IC-mediated sys-
tem, FcγR ligation and PMN adhesion are insufficientfor optimal MIP-2 release and ROI production and that
possibly integrin clustering and cytoskeletal reorgani-
zation are critical for these functions. To specifically
evaluate the role of adhesion in PMN effector functions,
we turned to a system in which we could stimulate
PMNs to adhere without undergoing cytoskeletal re-
arrangements. Mn2+ treatment of PMNs increases inte-
grin affinity directly, leading to cellular adhesion; how-
ever, in the absence of Ca2+, there is no cytoskeletal
reorganization (Leitinger et al., 2000). Indeed, Mn2+-
treated wt PMNs adhered efficiently to IC-coated sur-
faces; however, there was little cell spreading and
markedly diminished CD11b clustering (Figure 5A).
Mn2+-treated wt PMNs also displayed a hyperphos-
phorylation pattern when plated on IC or fibrinogen
(Figures 5B and 5C), suggesting a correlation between
hyperphosphorylation and lack of cytoskeletal reorga-
nization. In addition, Mn2+-treated, IC-stimulated wt
PMNs produced approximately 50% less ROI com-
pared with wt PMNs stimulated in the presence of Ca2+
and Mg2+ (Figure 5D). Lastly, Mn2+-treated, IC-stim-
Immunity
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(A) Labeled PMNs were plated on IC in the presence of TNF-α. At the indicated time points, the wells were washed, and the percentage of
adherent cells remaining in the wells was measured. Data are representative of five independent experiments.
(B) PMNs were plated for 1 hr on IC (in the presence of TNF-α), washed, and fixed with 2% paraformaldhehyde. CD11b staining was performed
on nonpermeabilized cells. For F-actin visualization, the cells were permeabilized with 0.1% Triton-X 100.
(C) Resting, TNF-α- or IC-stimulated PMNs were analyzed for surface levels of CD11b by flow cytometry.
(D) PMNs were stimulated on IC for the indicated time, and cell lysates were probed for total tyrosine phosphorylation (PY), phosphorylated
p85α, Paxillin, or Syk, and total Syk served as the loading control for protein content.
(E) PMNs were stimulated on IC for the indicated time, and Vav1 was immunoprecipitated with anti-Vav1 Abs. Western blots were performed
with Abs to PY or to Vav1. Vav1 phosphorylation was calculated from the ratio of anti-PY/total Vav1, and phosphorylation of wt PMNs at 15
min was set to 100%. Data are representative of two independent experiments.
(F) Rac1-GTP was precipitated with PAK-1PBD after 15 and 30 min of IC stimulation or after in vitro GTPγS protein loading, which activates
100% of Rac1 in protein lysates and serves as an internal control for protein loading content. Rac1 activation was calculated from the ratio
of IC-activated Rac1 and in vitro GTPγS loading, and Rac1 activation in wt at 15 min was set to 100%. Data are representative of three
independent experiments.ulated wt PMNs did not release MIP-2 (Figure 5E). t
zThese findings are not the result of a degranulation de-
fect, as release of NE from primary granules was normal i
Min the presence of Mn2+ (Figure S6). Treatment of cells
with anti-integrin Abs to artificially induce clustering did f
anot lead to MIP-2 production in the presence of Mn2+
(Figure 5F), suggesting that anti-integrin Abs can by- d
apass the requirement for high-affinity state but cannotlead to MIP-2 secretion in the absence of Ca2+ and cy-oskeletal rearrangements. Thus, cytoskeletal reorgani-
ation is critical for optimal MIP-2 and ROI production,
ndependent of adhesion. Treatment of wt PMNs with
n2+ therefore recapitulates some of the activation de-
ects seen in IC-stimulated CG/NE PMNs. These results
re consistent with the apparent normal adhesion but
efective effector functions observed in CG/NE PMNs
nd argue that CG’s and NE’s critical role is in the regu-lation of cytoskeletal reorganization.
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685Figure 5. Cytoskeletal Reorganization Is Critical for ROI and MIP-2 Production
(A) PMNs were stimulated on IC in the presence of Ca2+ and Mg2+ or Mn2+ and stained for CD11b or F-actin. PMNs were activated on IC (B)
or fibrinogen (C) in the presence of Ca2+ and Mg2+ or Mn2+ for the indicated times, and cell lysates were probed for total PY. Syk served as
the protein-loading control. ROI production (D) and MIP-2 release by wt PMNs plated on IC (E) or on anti-integrin Abs (F) in the presence of
Ca2+ and Mg2+ or Mn2+. MIP-2 on anti-integrin Abs was assayed at 2 hr. In (D)–(F), all values represent mean ± SD.Serine Proteases Are Not Required for Integrin
High-Affinity Conformational Changes
Normal adhesion of CG/NE PMNs to IC-coated sur-
faces suggests that CD11b has undergone a conforma-
tional change to the high-affinity state upon IC activation.
To further explore this notion, we used an experimental
system in which we could directly assess the CD11b
affinity state for ligand binding. In these experiments,
sheep erythrocytes were coated with iC3b (EiC3b) andused as test ligands. Activated CD11b binds to the
complement component iC3b (Berman and Muller,
1995; Jin and Li, 2002), and the extent of binding is
reflected in the number of rosette-forming PMNs. As
shown in Figure 6, a small percentage of PMNs plated
on OVA formed rosettes (9% ± 3% for wt and 11% ±
5% for CG/NE). The percentage of rosette-forming cells
was significantly increased when PMNs were plated on
IC in the presence of Mn2+ (94% ± 5% for wt and
Immunity
686Figure 6. IC-Stimulated PMNs Mediate Rosette Formation with EiC3b
(A) PMNs were plated on OVA or IC in the presence of Ca2+ and Mg2+ or Mn2+, and rosetting was performed as described in Experimental
Procedures. In some experiments, anti-CD11b antibody was added and allowed to incubate for 30 min prior to addition of EiC3b.
(B) Percentage of adherent cells with rosettes. Closed arrowheads indicate PMNs with rosettes; open arrowheads indicate PMNs without
rosettes, and the thin arrow indicates unbound erythrocyte. Note the flattened appearance of wt PMNs plated on IC compared with the more
rounded appearance of CG/NE PMNs. At least 200 PMNs were counted, and percent average represents mean ± SD from four randomly
chosen fields.93% ± 1% for CG/NE). IC stimulation in the presence b
eof Ca2+ and Mg2+ led to 86% ± 1% rosetting in CG/NE
PMNs, confirming that CD11b has been activated to 6
athe high-affinity state. Surprisingly, wt PMNs plated on
IC in the presence of Ca2+ and Mg2+ have a lower num-
ber of rosettes (25% ± 9%), perhaps because CD11b in E
Rwt PMNs may have redistributed to points of contacts
between cells and IC-coated surfaces and, therefore, T
mwas less available for binding EiC3b. Lastly, the rosetting
is CD11b-specific, as preincubation of cells with a glocking anti-CD11b antibody prior to the addition of
rythrocytes totally abrogated rosette formation (Figure
A). These results suggest that CG and NE are dispens-
ble for high-affinity integrin conformational changes.
xogenous Addition of Active Human Cathepsin G
econstitutes PMN Effector Functions
he fact that serine proteases remain bound to surface
embrane upon release from primary granules sug-
ests that they may modulate integrin clustering and
Cathepsin G Regulates Neutrophil Functions
687integrin-dependent signaling from the outside. If this
were true, then we should be able to restore MIP-2 re-
lease and ROI production by providing an exogenous
source of serine proteases. To test this hypothesis, we
added a physiologic dose of purified human CG (hCG)
to CG/NE PMNs stimulated with IC. Exogenously added
hCG completely restored the release of MIP-2 to wt
levels (Figure 7A). Similarly, the addition of exogenous
hCG also restored ROI production to near normal levels
in CG/NE PMNs (Figure 7B). To determine whether the
catalytic activity of hCG is required for reconstitution,
we performed the same experiments with inactivated
hCG (ihCG). Inactivation of hCG by PMSF totally abol-
ished the ability of the protease to reconstitute effector
functions in CG/NE PMNs (Figures 7A and 7B). To rule
out the possibility that ihCG could not reconstitute the
effector functions because of its inability to associate
with the cell surface of PMNs, we performed immuno-
fluorescence on CG/NE PMNs incubated in the ab-
sence or presence of hCG. Both active and inactive
forms of hCG were found to associate with the cell sur-
face (Figure 7C), suggesting that the catalytic activity
of hCG is not required for membrane association but
is critical for the regulation of PMN effector functions.
Strikingly, the addition of hCG alone, but not ihCG, also
restored the clustering pattern of CD11b in CG/NE
PMNs (Figures 7D and 7E), suggesting that the proteo-
lytic activity of CG is crucial for the reorganization of
surface β2 integrins in vitro.
Discussion
In this report, we identified a novel and important func-
tion of neutrophil-derived serine protease CG as a criti-
cal regulator of PMN effector functions during IC stimu-
lation. We found that CG/NE PMNs have severe defects
in MIP-2 release and ROI production. We showed that
CG/NE PMNs also exhibited significant defects in cell
signaling, including increased phosphorylation of Syk
and Vav1 as well as defective Rac1 activation. In addi-
tion, CG/NE PMNs failed to undergo cytoskeletal reor-
ganization, although they adhered normally to IC-
coated surfaces. Exogenously added, proteolytically
active CG largely restored these defects. Together,
these observations link neutrophil-derived serine prote-
ases to integrin-dependent, regulated chemokine se-
cretion and ROI production.
Much attention has been paid to the “affinity modula-
tion” models of integrin activation in which conforma-
tional changes of the extracellular domain of the het-
erodimers lead to rapid integrin-dependent adhesion
(Takagi and Springer, 2002). Although it is clear that af-
finity modulation plays a central role in regulating adhe-
sive properties of integrins, few studies have distin-
guished the precise role of “avidity modulation” or
clustering in integrin-mediated functions. However,
most of the issues over “affinity” versus “avidity” are
considered in the context of cellular adhesion rather
than cellular effector functions. Although enhanced af-
finity is sufficient for ligand binding and adhesion, we
propose that subsequent clustering of integrins that
leads to avidity modulation is essential for certain inte-
grin-mediated neutrophil effector functions. Consistentwith this interpretation, we showed that adhesion in-
duced by Mn2+, an activator of high-affinity ligand bind-
ing, was insufficient to cause release of MIP-2 or to
produce optimal levels of ROI in the absence of integrin
clustering and cell spreading. Although the release of
prestored granule content minutes after IC stimulation
was normal in the CG/NE PMNs, sustained and optimal
release of newly synthesized MIP-2 and ROI over time
may require cytoskeletal reorganization and the activa-
tion of the Rho family GTPases (Bokoch and Diebold,
2002; Burridge and Wennerberg, 2004). Indeed, data
suggest that the transport, maturation, and exocytosis
of nascent granules as they emerge from the trans-
Golgi network depend on the cooperative action of
microtubules and actin filaments (Rudolf et al., 2001).
In addition, optimal production of ROI requires the as-
sembly of the NADPH oxidase complex composed of
cytosolic components recruited to membrane bound
components after Rac GTPase activation (Bokoch and
Diebold, 2002). Our data therefore place CG directly in
a pathway that regulates Rac GTPase activation and
cytoskeletal reorganization (Figure 4F).
How does CG regulate integrin clustering and cy-
toskeletal rearrangements? We considered the possi-
bility that CG modulates integrin activity directly through
proteolytic modification of the extracellular domain of
these receptors. In fact, previous studies have shown
that NE and CG enhance the affinity of β3 integrin
through the limited proteolysis of the α subunit (Si-
Tahar et al., 1997). Although our results suggest that
CD11b in CG/NE PMNs was converted to an active
conformation upon IC stimulation (Figure 6), limited
proteolysis may further stabilize the high-affinity state,
expose ligand-induced binding site (LIBS) epitopes,
and promote clustering of integrins. To test this hypoth-
esis, we turned to the human system, as there are no
available antibodies that recognize high-affinity CD11b
in the murine system. To this end, we treated purified
human PMNs to exogenous hCG and monitored for
new LIBS with a well-characterized monoclonal anti-
body (clone CBRM1/5) (Oxvig et al., 1999) that recog-
nizes the active conformation of human CD11b. We
saw no evidence that hCG can directly expose new
LIBS when incubated with human PMNs in suspension
(data not shown). In addition, we found no evidence
that CD11b on the surface of IC-activated murine
PMNs was proteolytically processed by serine prote-
ases (data not shown). Thus, CG does not directly acti-
vate integrins.
We also explored the notion that serine proteases
may regulate integrin clustering indirectly through an-
other surface receptor. An intriguing class of receptors
on PMNs that may be specific targets of serine prote-
ases are the protease-activated receptors (PARs). PARs
are G protein-coupled receptors that undergo proteo-
lytic cleavage of the N terminus, thus exposing a teth-
ered ligand that subsequently autoactivates the recep-
tors (Coughlin and Camerer, 2003; O’Brien et al., 2001).
Among the four PARs described to date, PAR-2 is ex-
pressed on PMNs (Howells et al., 1997). To examine
whether chemokine and ROI production by murine
PMNs is dependent on PAR-2 activation by CG, we
sought to bypass the requirement for PAR-2 proteolytic
cleavage by stimulating CG/NE PMNs directly with an
Immunity
688Figure 7. Exogenously Added hCG Restores PMN Functions
Wt and CG/NE PMNs were plated on IC in the absence or presence of hCG or ihCG and assayed for MIP-2 release (A) or ROI production (B)
over time. Data represent the mean ± SD of at least two independent experiments. ROI data are presented as percentage of wt PMNs at
125 min.
(C) hCG and ihCG both associate with cell surface; hCG (red) and CD11b (green).
(D) hCG, but not ihCG, restored CD11b clustering in CG/NE PMNs.
(E) Percentage of cells with CD11b clustering (defined as a punctate pattern seen around at least 50% of the cell contact points). At least
400 cells per condition were individually counted and the values represent mean ± SD as determined by two blinded observers.
(F) A model of CG-regulating PMN effector functions. IC stimulation and FcγR ligation leads to degranulation and increased integrin affinity.
CG released from the cell remains bound to the surface membrane and regulates integrin clustering, Rac1 activation, and cytoskeletal
reorganization that subsequently leads to ROI production and MIP-2 secretion. Mn2+ increases integrin affinity directly but does not lead to
cytoskeletal reorganization in the absence of Ca2+. Anti-integrin Abs can bypass the high affinity requirement for integrin ligand binding but
does not lead to cytoskeletal reorganization in the absence of CG.agonist peptide, SLIGRL (Moffatt et al., 2002). However, m
ewe did not detect any enhancement of MIP-2 secretion
or ROI production with the addition of this peptide ago- t
Nnist (data not shown). Another CG receptor on PMNs
that was recently identified is the G protein-coupled u
ffMLP receptor (Sun et al., 2004). In the human system,
CG can act as an agonist to induce chemotaxis ofonocytes and PMNs through the fMLP receptor. How-
ver, our findings that PTX, a G protein-coupled recep-
or inhibitor, did not affect MIP-2 release in wt or CG/
E PMNs while significantly inhibiting chemotaxis (Fig-
re S3) suggests that these two functions require dif-
erent signaling pathways.
Finally, these in vitro data of serine protease modula-
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689tion of PMN effector functions offer a possible explana-
tion for the in vivo observations of impaired PMN re-
cruitment and decreased chemokine production in the
air pouch. The initial PMNs recruited to the site of IC-
induced inflammation release serine proteases that
help regulate PMN effector functions in an autocrine
fashion. The chemokines secreted by PMNs promote
further influx of leukocytes and activate proximal cells
to release more proinflammatory factors. In addition to
this autocrine regulation of PMN functions, serine pro-
teases themselves have been shown in vitro to cause
cytokine and chemokine release from resident cells
such as macrophages and epithelial cells (Coeshott et
al., 1999; Fadok et al., 2001; Sugawara et al., 2001). The
direct or indirect effect of serine proteases on resident
cells may explain the substantially higher levels of CXC
chemokines released into the air pouch. In addition,
ROI can also contribute to inflammation by causing
metabolic dysfunction and tissue damage (Mylonas
and Kouretas, 1999); the overall effects are to generate
more inflammatory signals. CG/NE PMNs lack the po-
tential to sustain optimal levels of chemokine release
and ROI production, resulting in a severely blunted in-
flammatory response or in early termination of the in-
flammatory response.
In summary, our results suggest a model in which IC
activation leads to the release of granule-associated
serine proteases CG and NE. The proteases remain
bound to the cell surface where CG acts to increase
integrin clustering and to enhance integrin-mediated
functions in PMNs (Figure 7F). Identification of this CG
substrate would likely yield significant insights into ser-
ine protease functions and integrin activation. Nonethe-
less, our findings of CG’s role in PMN activation raise
unexpected and interesting questions regarding the
general role of serine proteases in integrin-mediated
cellular functions in general. Whereas CG is essentially
PMN-specific, similar serine proteases are found in
other cell types (i.e., mast cell chymase). Because inte-
grins are widely expressed cellular receptors, we envi-
sion that this novel view of integrin avidity modulation
by serine proteases may be relevant in other cell sys-
tems as well.
Experimental Procedures
Mice
CG−/−, NE−/−, and CG/NE mice on the 129 genetic background were
generated as previously described (Belaaouaj et al., 1998; MacIvor
et al., 1999). These mice and wt control mice were kept in patho-
gen-free conditions at Washington University Specialized Research
Facility. For in vitro analysis, mice 5–8 weeks of age were used. For
in vivo analysis, mice 6–8 weeks of age were used.
Subcutaneous Air Pouch Model
Air pouches were formed as previously described. All in vivo exper-
iments were preformed on day 6 air pouches. Reverse passive Ar-
thus reaction and zymosan injection were performed as previously
described (Adkison et al., 2002). After 4 hr, the number of leuko-
cytes was enumerated, and chemokine levels were assayed by
specific ELISA (R&D Systems).
PMN Purification
PMNs were isolated from bone marrow by discontinuous Percoll
(Amersham 17-0891) gradient as previously described (Adkison etal., 2002). PMN purity was 75%–85% as assessed by forward and
side scatter with flow cytometry.
In Vitro PMN Stimulation
ICs were formed by coating tissue culture plates with 5 mg/ml OVA
(Sigma A5503) overnight at 4°C followed by rabbit anti-OVA serum
(Sigma C6534) at 25 g/ml (unless otherwise noted). Alternatively,
plates were coated with fibrinogen (200 g/ml, Sigma F9754), fibro-
nectin (200 g/ml, Sigma F0895), 40 g/ml of anti-CD16 (Phar-
mingen 553142), anti-CD11b (Serotec MCA711), anti-CD29 (Phar-
mingen 553715) Abs, or rat IgG2a as isotype control (Pharmingen
553926) and blocked with 5 mg/ml OVA. Purified PMNs (at 5 × 106
cell/ml) in X-VIVO 10 Media (BioWhittaker 04-380Q) or KRP buffer
(PBS, 1 mM Ca2+, 1.5 mM Mg2+, and 5.5 mM glucose) were plated
on IC at 300 l per well in 24-well plates in the presence of 10 ng/
ml TNF-α. In some experiments, PMNs were stimulated on IC in the
presence of 1 mM Mn2+ instead of Ca2+ and Mg2+ and incubated at
37°C for the indicated times. As controls, PMNs were stimulated
with 200 ng/ml of PMA.
Chemokine Analysis
Concentrations of MIP-2 were determined by ELISA (R&D Systems)
and carried out as described in the manufacturer’s protocols. PMN
pellets were resuspended in 300 l of PBS and 0.1% Tween 20,
freeze-thawed three times, and cleared by centrifugation prior to
ELISAs. Total amount of MIP-2 was calculated from the formula
(MIP-2 in supernatant + MIP-2 in cell pellets).
MIP-2 Analysis by Flow Cytometry
Intracellular chemokine analysis and surface staining were per-
formed as previously reported (Dorner et al., 2002) with the follow-
ing modifications. Intracellular staining was performed with anti-
MIP-2 Abs (R&D Systems, AF-452), and anti-Gr-1 Abs (Pharmigen
553128) were used for PMN surface staining.
Western Blot Analysis
Activated PMNs were lysed directly in 2× SDS sample buffer, boiled
for 5 min, and fractionated with 10% sodium dodecyl-sulfate-poly-
acrylamide gel electrophoreses (SDS-PAGE). The blots were
probed for total phosphotyrosine (4G10, Upstate 05-321), phos-
pho-Syk (Tyr323/525/526, Cell Signaling 2711 and 2715), phospho-
PI 3-kinase p85α (Tyr508, Santa Cruz SC-12929), phospho-Paxillin
(Ser178, Bethyl Laboratories A300-100), or Syk (Santa Cruz N-19)
followed by the appropriate peroxidase-conjugated secondary an-
tibodies (Jackson ImmunoResearch). Three million PMNs were
lysed in RIPA-based buffer (Mocsai et al., 2002), immunoprecipi-
tated with anti-Vav1 Abs (Santa Cruz H-211), and probed with 4G10
and anti-Vav1 Abs followed by the respective secondary Abs.
PMNs were activated on IC, and Rac1 activation was performed
according to the manufacturer’s instructions (Upstate Biotechnol-
ogy 17-283).
Respiratory Burst
ROI was measured with OxyBURST Green H2HFFBSA (Molecular
Probes O-13291) or Dihydrorhodamine 123 (Molecular Probes
D-632) and carried out according to the manufacturer’s instruc-
tions. PMNs were resuspended at 5 × 106 cell/ml with 10 ng/ml
TNF-α and plated in triplicates in 96-well plates at 100 l per well.
Fluorescence was measured over time at 480 nm excitation and
520 nm emission wavelengths with a FL500 microplate fluores-
cence reader (BIO-TEK Instruments). Specific ROI production was
calculated with the following formula: [Fluorescence generated by
cells plated on specific ligands − nonspecific fluorescence gener-
ated by cells plated on OVA or anti-OVA].
Adhesion Assay
Purified PMNs (5 × 106 cell/ml) were labeled with calcein AM (Mo-
lecular Probes C3100) at 5 g/ml for 30 min at 37°C. Labeled cells
at 5 × 105 in 100 l of KRP buffer were plated on IC in 96-well
plates with TNF-α (10 ng/ml). At the indicated time, wells were
washed twice with PBS to remove nonadherent cells. The fluores-
cence was measured at 480 nm excitation and 520 nm emission.
The percentage of adherent cells was determined by the following
Immunity
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kfore wash] × 100.
B
Exogenous Reconstitution with Human CG h
Human CG (hCG) (Elastin Products SG623) and inactivated hCG t
(ihCG) were added at the beginning of the assays at a final concen- s
tration of 1 g/ml for MIP-2 reconstitution or 2 g/ml for ROI recon- B
stitution. hCG was inactivated with 2 mM phenylmethanesulfonyl l
fluoride (PMSF) in 0.1 M Tris (pH 8) for 2 hr at 37oC and dialyzed n
for 4 hr to overnight in 0.1 M Tris (pH 8). The remaining enzymatic C
activity was determined by using the CG substrate N-succinyl-Ala-
BAla-Pro-Phe-pNA as previously described (Adkison et al., 2002).
f
2Fluorescent Microscopy
BLAB-TEK permanox chamber slides (Nalge Nunc) were coated with
sIC, and PMNs were plated on slides in the presence of TNF-α. After
1 hr, slides were washed twice with PBS and fixed with 2% parafor- C
maldehyde for 20 min. PMNs were stained for F-actin with Texas a
Red-X phalloidin (Molecular Probes T-7471). Surface staining for A
CD11b (Pharmingen 557396) was performed on nonpermeabilized, C
paraformaldehyde-fixed cells. hCG staining was performed with (
guinea pig anti-human CG (a generous gift from Tim Ley) followed a
by rhodamine red-X-conjugated donkey anti-guinea pig (Jackson h
ImmunoResearch 706-295-148). All images were visualized on a Ni- a
kon Eclipse microscope and acquired with Magnafire software
C(Optronics).
MRosetting Assay iC3b-coated sheep erythrocytes (EiC3b) were
(prepared as previously described (Jin and Li, 2002). Briefly, anti-
nbody-sensitized sheep erythrocytes (Advanced Research Technol-
Cogies B200) were washed three times in DGVB2+ (2.5 mM veronal
Mbuffer [pH 7.5], 75 mM NaCl, 2.5% dextrose, 0.05% gelatin, 0.5 mM
eMgCl2, 0.15 mM CaCl2), incubated with 20% mouse serum for 1 hr
1at 37°C, and washed three times with DGVB2+. 5 × 107 EiC3b were
oadded to IC-stimulated PMNs in the presence of Ca2+ and Mg2+ or
SMn2+-containing buffers for 30 min at 37°C in a total volume of 250
l. In some experiments, anti-CD11b Abs (1 g/ml) were added to C
the PMNs prior to EiC3b addition and allowed to bind for 30 min at t
room temperature. After unbound EiC3b were washed away, the D
cells were fixed in 2.5% gluteraldehyde, and the number of rosettes n
(determined as PMNs with at least three attached EiC3b’s) was de-
D
termined by counting at least 200 PMNs in four randomly chosen
S
fields.
p
g
USupplemental Data
F
fSupplemental Data including six figures are available online with
pthis article at http://www.immunity.com/cgi/content/full/22/6/679/
6DC1/.
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